Biofil Chemicals & Pharmaceuticals Ltd.

34.22

0.5 (1.5%)growUp

BIOFILCHEM Share Price
As on April 28, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap56 Cr
P/E Ratio99.85
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open33.72
High35.5
NSE SymbolBIOFILCHEM
Close34.22
Low33.53
BSE Symbol524396
Previous Years High/Low
1 Year High57.19
3 Year High91.87
5 Year High107
1 Year Low25.6
3 Year Low25.6
5 Year Low25.6

Technicals


IndicatorsValueSignal
5-DMA33.76Bullish
10-DMA34.04Bullish
20-DMA32.24Bullish
50-DMA32.01Bullish
100-DMA32.96Bullish
200-DMA37.6Bearish

Historical Performance


1 Year
-24%
3 Years
-25.5%
5 Years
-58.3%
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:-15.2
3 Years:-9.4
TTM:-23.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 99.85, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -8.8%, indicating poor shareholder returns.
  • The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹12 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹334 million, indicating a relatively small business scale.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 761290.3
No. of Shares: 22247 (Approx)
Performance:-23.9%
P/L: ₹-238709.7
NIFTY Performance: -1.4%
1 day Top Gainers
SymbolChange%
COHANCE493.3(14%)
TATACHEM802.15(11%)
CHENNPETRO1072.3(8%)
RKFORGE602.3(7%)
RRKABEL1609(7%)
1 Day Top Losers
SymbolChange%
MSUMI39.24(-5%)
TATATECH569.8(-4%)
ZENSARTECH528.2(-4%)
ONESOURCE1763(-4%)
INDIACEM419.2(-4%)
ELECON479.2(-4%)
SBICARD647.45(-4%)
CANFINHOME883.3(-4%)

Top Performing Stocks from the same sector


Aarey Drugs & Pharmaceuticals Ltd.

70.3%

95.19

1 Month Performance

Cohance Lifesciences Ltd.

63%

493.3

1 Month Performance

Balaxi Pharmaceuticals Ltd.

61%

26.54

1 Month Performance

Vaishali Pharma Ltd.

55.4%

8.05

1 Month Performance

Valiant Laboratories Ltd.

48.6%

79.62

1 Month Performance

Gujarat Themis Biosyn Ltd.

47.1%

370.48

1 Month Performance

Brooks Laboratories Ltd.

43%

61.78

1 Month Performance

Kopran Ltd.

40.3%

159.18

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month